Table 4.
Rejection, infection, and other outcomes
| ATG (n = 15) | DZM (n = 15) | p value | |
|---|---|---|---|
| Mean biopsy grade |
0.4 |
0.3 |
0.09 |
| Patients experiencing rejection |
2 (13%) |
0 |
0.5 |
| Total number of acute rejections |
2 |
0 |
0.2 |
| Time to first rejection episode (days) |
84 |
- |
- |
| Patients experiencing infection |
10 (67%) |
10 (67%) |
1.0 |
| Total number of infections |
25 |
21 |
0.7 |
| Infections/patient |
1.7 |
1.4 |
0.7 |
| Patients experiencing severe infection |
4 (27%) |
5 (33%) |
1.0 |
| Number of severe infections |
7 |
7 |
1.0 |
| Severe infections/patient |
0.5 |
0.5 |
1.0 |
| Number of CMV infections |
1 |
2 |
1.0 |
| Malignancy |
0 |
1 |
1.0 |
| Steroid-induced diabetes |
2 |
2 |
1.0 |
| Re-transplant |
0 |
0 |
- |
| ICU length of stay (days) |
11 ± 4 |
12 ± 4 |
09 |
| Total hospital length of stay (days) |
29 ± 8 |
27 ± 6 |
0.8 |
| One-month survival |
93% |
100% |
0.1 |
| One-year survival | 87% | 87% | 0.1 |